Easton Pharmaceuticals Provides Update on mPACT-Grozone 60(TM) and Other Corporate Initiatives
Marketwire - Wed Jul 16, 11:59AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) - Announces It is scheduled at the end of July to participate with Amfil Technologies Inc. in the introduction of the first mPACT-Grozone 60(TM) unit.
Easton Pharmaceuticals Announces Legal Action Against Seeking Alpha Writer as a Response to Libelous Article
Marketwire - Tue Jul 08, 2:00PM CDT
Easton Pharmaceuticals (OTC: EAPH) announces corporate response to libelous seeking alpha article.
Easton Pharmaceuticals Announces Closing of Agreement to Invest and Acquire Ownership Interest in AMFIL Technologies Inc. and the mPact -GROzone Antimicrobial Systems Line of Products
Marketwire - Tue Jul 08, 12:30PM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) - announces that it has advanced funds and closed on an agreement to invest and purchase an ownership interest in AMFIL Technologies Inc. and The mPact -GROzone Antimicrobial Systems Line of Products.
Cannabis Sativa & Easton Pharmaceuticals Led Cannabis Stocks Higher Last Week
ACCESSWIRE - Tue Jul 08, 8:07AM CDT
Whitefish, MT / July 8, 2014 / The Marijuana Index(tm) was mixed last week, as index heavyweights GW Pharmaceuticals plc (NASDAQ: GWPH) and Medbox Inc. (OTC: MDBX) gave up some of their earlier gains towards the end of the week.
Daily OTC Stocks Trading List: Easton Pharmaceuticals, Inc. Virtus Oil and Gas Corp, Primco Management, Inc. Baltia Airlines, Inc. Alternative Fuels America, Inc.
PR Newswire - Tue Jul 08, 7:00AM CDT
After releasing positive news regarding their latest build out and working partnerships shares in Easton Pharmaceuticals (OTC: EAPH) had been on a string move higher over the last week. That changed yesterday when after an impressive run to the upside shares rolled over to close down 15.7% on the day. It remains to be seen if this was just profit taking or a trading pullback, either way if the stock can get back above the $0.025 level then it has more upside potential.
Easton Pharmaceuticals Inc. Announces Medical Marijuana Facility Buildout Nears Completion as per MMPR Health Canada Guidelines Prior to Inspection Towards Obtaining MMJ Growers License
Marketwire - Tue Jul 01, 7:01AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) a specialty pharmaceutical company provides status update on its medical marijuana initiative.
Marijuana Sector Positioned to Move Higher as FDA Reviews Drug's Status
ACCESSWIRE - Mon Jun 30, 8:32AM CDT
WHITEFISH, MT / June 30, 2014 / The Marijuana Index(TM) traded marginally lower last week after MedBox Inc. (OTC: MDBX) and CannaVEST Corp.'s (OTC: CANV) moves lower offset GW Pharmaceuticals plc's (NASDAQ: GWPH) modest gains.
Easton Pharmaceuticals Finalizing Investment Terms in Private Medical Marijuana Device Company; Moves to Initiate Legal Action Against Libelous Seeking Alpha Article
Marketwire - Wed Jun 25, 12:17PM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) is near final agreement with a medical marijuana technology company specializing in controlled environment agricultural technologies.
Easton Pharmaceuticals Announces 2 Medical Marijuana Investment Proposals Which Include the Launch of Medical Marijuana Dispensary(s) in the State of Michigan and an Investment Into Medical Marijuana Technologies to Assist Growers With Harvests
Marketwire - Fri Jun 06, 11:42AM CDT
Easton Pharmaceuticals Inc. -- (OTC: EAPH) -- announces it has received and is in late stage discussions with two investment proposals in the medical marijuana industry.
Easton Pharmaceuticals Announces New Non-Dilutional Financing Source to Be Utilized Towards Its Medical Marijuana Initiative and Acquisitions
Marketwire - Thu Jun 05, 2:06AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has located a new source of non-dilutional financing.
OTC Trading Sector Focus List: Abakan, Inc. MyECheck, Inc. Easton Pharmaceuticals, MRI Interventions, Infinex Ventures
PR Newswire - Wed Jun 04, 7:58AM CDT
Trading in the small cap markets over the summer in be a volatile time and the close yesterday was no exception. Today we focus on a group of stocks trading within the OTC that were substantially higher but may have pulled back intra-day due to profit taking from traders therefore making a cheaper price entry point.
Easton Pharmaceuticals signs agreement to purchase an ownership interest in a medical marijuana operation in Canada
M2 - Tue Jun 03, 4:10AM CDT
Easton Pharmaceuticals Inc (OTC: EAPH), a specialty pharmaceutical company involved in various pharmaceutical sectors including medical marijuana, announced on Monday the signing of an agreement to purchase an interest in a pending medical marijuana operation.
Easton Pharmaceuticals Announces the Closing of Medical Marijuana Agreement With MDRM Group (Canada) Ltd., on Purchasing an Ownership Interest in a Growers License in Canada's Federal Medical Marijuana Industry
Marketwire - Mon Jun 02, 8:42AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has signed an agreement to purchase an interest in a pending medical marijuana operation.
Optimizing Operations Continue for Legal Marijuana Industry - Company Acquires Option for Cannabis Genetic Catalog for 22 Unique Strains
PR Newswire - Thu May 29, 7:50AM CDT
Cannabis companies dealing with Legal Medical Marijuana Industry continue to make progress by developing products through advancements, acquisitions and research: OSL Holdings (OTC: OSL), Cannabis Science, Inc. (OTC: CBIS), Easton Pharmaceuticals Inc. (OTC: EAPH), GreenGro Technologies, Inc. (OTC: GRNH) and Vape Holdings, Inc. (OTC: VAPE)
CannabisFN Weekly: Water Rights Could Become an Issue for Cannabis Growers
ACCESSWIRE - Tue May 27, 8:01AM CDT
Whitefish, MT / ACCESSWIRE / May 27, 2014 / The Marijuana Index™ moved modestly lower last week amid lackluster performance by bellwethers like GW Pharmaceuticals Ltd. (NASDAQ: GWPH) and CannaVEST Corp. (OTC: CANV), which traded down 0.88% and 69.5%, respectively.
CannabisFN Weekly: Cannabis Sector Gears Up for Canada's MMPR
ACCESSWIRE - Mon Mar 31, 8:01AM CDT
Whitefish, MT / March 31, 2014 / The Marijuana Index™ moved lower over the past week due in large part to a 40% drop in shares of Cannavest Corp. (OTCBB: CANV) along with broader declines across the sector. Many traders appeared to be locking in profits after a volatile start to 2014 although cannabis stocks showed signs of recovery during Friday's session and long-term industry catalysts like regulatory reform remain very intact.
Easton Pharmaceuticals Announces Changes in Management and New Additions to Advisory Board; Appoints Dr. Albert PhD as New Marketing and Technology Officer and Appoints Tim Zorn, Current CEO of HempLifeToday.com to Advisory Board
Marketwire - Mon Mar 31, 7:03AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) -- announces it has appointed Carla Pepe as its new CEO and President, replacing John Adams who will assume the position of CFO. The company also announces the addition of Dr. Lilla Albert PhD to the advisory board, chief marketing officer, and Mr. Tim Zorn, current CEO of HempLifeToday.com (OTC: GLCO) to advisory board.
Easton Pharmaceuticals Announces Signing LOI for Joint Venture Towards Private Medical Marijuana Colorado Grower and Licenses; Provides Clarification on Its Canadian Medical Marijuana Initiatives
Marketwire - Fri Mar 28, 9:45AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it has signed a letter of intent for the creation of a possible JV with another US company towards a Private Medical Marijuana company in the state of Colorado.
Easton Pharmaceuticals Announces Update to Its Cancer Drug Initiative: Majority Acquisition, Patent Strategy and Clinical Development Along With New Partnership Proposal Involving Medicinal Marijuana Drug Development
Marketwire - Tue Mar 25, 7:46AM CDT
Easton Pharmaceuticals, Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, announces it has entered into an agreement towards securing majority control of the cancer drug Xilive, pending certain conditions and a new partnership proposal towards medicinal marijuana.
Cannabis Science Finalizes $1 Million in New Financing
ACCESSWIRE - Wed Mar 19, 10:22AM CDT
A developer of cannabis-based pharmaceutical products Cannabis Science Inc. (NASDAQ OTC: CBIS) announced that it has finalized its $1,000,000 private placement and the funds have already been put into the bank.